Dosage and administration
Take one caplet by mouth daily or as directed by a physician.
OB Complete Prenatal
- Manufacturer
- Vertical Pharmaceuticals, LLC
- Effective date
- 2019-12-11
- Label type
- DIETARY SUPPLEMENT
- Version
- 7
- Source
- full-release
- Hydrated at
- 2026-06-01 02:50:20
Label at a glance#
ProductOB Complete Prenatal
Active ingredientBETA CAROTENE, ascorbic acid, cholecalciferol, .alpha.-tocopherol succinate, D-, THIAMINE MONONITRATE, Riboflavin, NIACINAMIDE, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Pantothenic Acid, IRON PENTACARBONYL, Magnesium Oxide, Zinc Oxide, COPPER GLUCONATE
Label structure12 sections
Contacts and useful links#
Websitewww.fda.gov
www.fda.gov/medwatch
www.fda.gov/medwatchWebsitewww.verticalpharma.com
www.verticalpharma.com
www.verticalpharma.comLabel contents#
Full prescribing information#
SUPPLEMENT FACTS
Other Ingredients: Microcrystalline Cellulose, Di Cal Phosphate, Croscarmellose Sodium, Pink Color Coating (Hydroxypropylmethyl Cellulose, Polyvinyl Alcohol, Titanium Dioxide, Polyethylene Glycol, Talc and FDC Red #40 Lake), Fumed Silica, Stearic Acid, Magnesium Stearate, Povidone K30, Acacia
GLUTEN-, LACTOSE- AND SUGAR-FREE
OB Complete® is a prescription multivitamin/multimineral indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and non-lactating mothers.
HEALTH CLAIM SECTION
Other Ingredients: Microcrystalline Cellulose, Di Cal Phosphate, Croscarmellose Sodium, Pink Color Coating (Hydroxypropylmethyl Cellulose, Polyvinyl Alcohol, Titanium Dioxide, Polyethylene Glycol, Talc, FD&C Red #40 Lake), Fumed Silica, Stearic Acid, Magnesium Stearate, Povidone K30, Acacia.
GLUTEN, SUGAR AND LACTOSE FREE
CONTRAINDICATIONS
OB Complete® should not be used by patients with a known hypersensitivity to any of the listed ingredients.
WARNINGS
| WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately. |
PRECAUTIONS
Folic acid alone is an improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurologic manifestations remain progressive. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.
DRUG INTERACTIONS
OB Complete® caplets are not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, Clopidogrel).
ADVERSE REACTIONS
Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients
DESCRIPTION
OB Complete® is pink, capsule shaped caplet imprinted with "VP010".
DIRECTIONS FOR USE
Take one caplet by mouth daily or as directed by a physician.
HOW SUPPLIED
OB Complete® is supplied in a unit dose pack of 100 (10x10) caplets.
Product Code: 68025-010-10
STORAGE
Store at controlled room temperature 15°-30°C (59°-86°F) [See USP]. Protect from light, moisture and avoid excessive heat.
WARNINGS SECTION
KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.
For use on the order of a healthcare practitioner
Call your doctor about side effects. To report side effects, call Vertical Pharmaceuticals at 1-770-509-4500 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
PLR-OBCPRE-00002-1 Rev. 12/2021
Distributed by:
Vertical Pharmaceuticals, LLC
Alpharetta, GA 30005
PRINCIPAL DISPLAY PANEL - 100 Caplet Blister Pack Carton
OB Complete® Prenatal Multivitamin
NDC 68025-010-10
100 CAPLETS
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CHOLECALCIFEROL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CYANOCOBALAMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68025-010-10 | OB Complete Prenatal | 10 in 1 CARTON | TABLET | 10 | 7 | |
| 68025-010-10 | OB Complete Prenatal | 10 in 1 BLISTER PACK | TABLET | 10 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68025-010 | OB COMPLETE PRENATAL (.BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL SUCCINATE, D-, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, PANTOTHENIC ACID, IRON PENTACARBONYL, MAGNESIUM OXIDE, ZINC OXIDE, AND COPPER GLUCONATE) TABLET [VERTICAL PHARMACEUTICALS, LLC] | 7 | 2 package rows | 20220128_1c91079b-546e-400a-a342-b2223cd26a01.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68025-010-10 | EA - Each | 68025-010 | 4a8e5b10-edee-46e0-9e08-0f42309f90be | 1 | 2013-07-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .alpha.-tocopherol succinate, D- | ACTIVE INGREDIENT | LU4B53JYVE | 2 | |
| .beta.-carotene | ACTIVE INGREDIENT | 01YAE03M7J | 2 | |
| ascorbic acid | ACTIVE INGREDIENT | PQ6CK8PD0R | 2 | |
| cholecalciferol | ACTIVE INGREDIENT | 1C6V77QF41 | 2 | |
| COPPER GLUCONATE | ACTIVE INGREDIENT | RV823G6G67 | 2 | |
| Cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | 2 | |
| Folic Acid | ACTIVE INGREDIENT | 935E97BOY8 | 2 | |
| IRON PENTACARBONYL | ACTIVE INGREDIENT | 6WQ62TAQ6Z | 2 | |
| Magnesium Oxide | ACTIVE INGREDIENT | 3A3U0GI71G | 2 | |
| NIACINAMIDE | ACTIVE INGREDIENT | 25X51I8RD4 | 2 | |
| Pantothenic Acid | ACTIVE INGREDIENT | 19F5HK2737 | 2 | |
| Pyridoxine Hydrochloride | ACTIVE INGREDIENT | 68Y4CF58BV | 2 | |
| Riboflavin | ACTIVE INGREDIENT | TLM2976OFR | 2 | |
| THIAMINE MONONITRATE | ACTIVE INGREDIENT | 8K0I04919X | 2 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 2 | |
| .alpha.-tocopherol, D- | ACTIVE MOIETY | N9PR3490H9 | 2 | |
| .beta.-carotene | ACTIVE MOIETY | 01YAE03M7J | 2 | |
| ascorbic acid | ACTIVE MOIETY | PQ6CK8PD0R | 2 | |
| cholecalciferol | ACTIVE MOIETY | 1C6V77QF41 | 2 | |
| CUPRIC CATION | ACTIVE MOIETY | 8CBV67279L | 2 | |
| Cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | 2 | |
| FERROUS CATION | ACTIVE MOIETY | GW89581OWR | 2 | |
| Folic Acid | ACTIVE MOIETY | 935E97BOY8 | 2 | |
| Magnesium Cation | ACTIVE MOIETY | T6V3LHY838 | 2 | |
| Niacinamide | ACTIVE MOIETY | 25X51I8RD4 | 2 | |
| Pantothenic Acid | ACTIVE MOIETY | 19F5HK2737 | 2 | |
| Pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 2 | |
| Riboflavin | ACTIVE MOIETY | TLM2976OFR | 2 | |
| THIAMINE ION | ACTIVE MOIETY | 4ABT0J945J | 2 | |
| Zinc Cation | ACTIVE MOIETY | 13S1S8SF37 | 2 | |
| acacia | INACTIVE INGREDIENT | 5C5403N26O | 2 | |
| Calcium Phosphate | INACTIVE INGREDIENT | 97Z1WI3NDX | 2 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 2 | |
| Croscarmellose Sodium | INACTIVE INGREDIENT | M28OL1HH48 | 2 | |
| FD&C Red No. 40 | INACTIVE INGREDIENT | WZB9127XOA | 2 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | 2 | |
| Magnesium Stearate | INACTIVE INGREDIENT | 70097M6I30 | 2 | |
| Polyethylene Glycols | INACTIVE INGREDIENT | 3WJQ0SDW1A | 2 | |
| polyvinyl alcohol | INACTIVE INGREDIENT | 532B59J990 | 2 | |
| povidone K30 | INACTIVE INGREDIENT | U725QWY32X | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 2 | |
| Talc | INACTIVE INGREDIENT | 7SEV7J4R1U | 2 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 2 |
Products#
Every source-derived product name is available through these pages.
- OB Complete Prenatal
- .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol succinate, D-, THIAMINE MONONITRATE, Riboflavin, NIACINAMIDE, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Pantothenic Acid, IRON PENTACARBONYL, Magnesium Oxide, Zinc Oxide, and COPPER GLUCONATE
- BETA CAROTENE
- ascorbic acid
- cholecalciferol
- .alpha.-tocopherol succinate, D-
- .alpha.-tocopherol, D-
- THIAMINE MONONITRATE
- THIAMINE ION
- THIAMINE
- Riboflavin
- NIACINAMIDE
- Pyridoxine Hydrochloride
- Pyridoxine
- Folic Acid
- Cyanocobalamin
- Pantothenic Acid
- IRON PENTACARBONYL
- FERROUS CATION
- Magnesium Oxide
- Magnesium Cation
- Zinc Oxide
- Zinc Cation
- COPPER GLUCONATE
- CUPRIC CATION
- cellulose, microcrystalline
- CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
- Croscarmellose Sodium
- hypromelloses
- POLYVINYL ALCOHOL, UNSPECIFIED
- titanium dioxide
- POLYETHYLENE GLYCOL, UNSPECIFIED
- Talc
- FD&C Red No. 40
- SILICON DIOXIDE
- stearic acid
- Magnesium Stearate
- povidone K30
- acacia
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 68025-010 | 68025-010-10 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED / ORAL | 176 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | 68 mg | ||
| acacia | ACACIA | 5C5403N26O | TABLET, DELAYED RELEASE / ORAL | 30 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION, EXTENDED RELEASE / ORAL | 70 mg | ||
| FD&C Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | SOLUTION / ORAL | 38 mg | ||
| Talc | TALC | 7SEV7J4R1U | PELLET / ORAL | 69 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / RESPIRATORY (INHALATION) | 2 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED / ORAL | 17 mg | ||
| acacia | ACACIA | 5C5403N26O | TABLET, ORALLY DISINTEGRATING / ORAL | 7 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, DELAYED RELEASE / ORAL | 1060 mg | ||
| polyvinyl alcohol | POLYVINYL ALCOHOL | 532B59J990 | CAPSULE / ORAL | 1.67 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, COATED PELLETS / ORAL | 456 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / BUCCAL | 3 mg | ||
| polyvinyl alcohol | POLYVINYL ALCOHOL | 532B59J990 | SUSPENSION / ORAL | 5 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | CAPSULE, DELAYED RELEASE / ORAL | 227 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION / ORAL | 200 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | DROPS / ORAL | NA | ||
| FD&C Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET / BUCCAL | 0.01 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE / ORAL | 1190 mg | ||
| FD&C Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, FILM COATED / ORAL | 2.5 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | SUSPENSION / ORAL | 148 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, LIQUID FILLED / ORAL | 12 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | SUSPENSION / ORAL | 150 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | INSERT, EXTENDED RELEASE / OPHTHALMIC | 0.4 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SUSPENSION / ORAL | 113 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CREAM / TOPICAL | 80 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | CREAM / VAGINAL | 1088 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, DELAYED RELEASE / ORAL | 105 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / RESPIRATORY (INHALATION) | 0.13 mg | ||
| Calcium Phosphate | CALCIUM PHOSPHATE | 97Z1WI3NDX | TABLET, EXTENDED RELEASE / ORAL | 352.63 mg | ||
| FD&C Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Calcium Phosphate | CALCIUM PHOSPHATE | 97Z1WI3NDX | PASTE, DENTIFRICE / DENTAL | 45.93 %w/w | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | TABLET, CHEWABLE / ORAL | 245 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, DELAYED RELEASE / ORAL | 80 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 20 mg | ||
| acacia | ACACIA | 5C5403N26O | SUSPENSION / INTRAMUSCULAR | 1 mg | ||
| Talc | TALC | 7SEV7J4R1U | DROPS / ORAL | NA | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | TROCHE / ORAL | 175 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | AEROSOL, FOAM / TOPICAL | 1.9 %w/w | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 144 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg | ||
| Calcium Phosphate | CALCIUM PHOSPHATE | 97Z1WI3NDX | POWDER, DENTIFRICE / DENTAL | 0.11 mg/mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | GRANULE / ORAL | 202 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | SYSTEM / INTRAVITREAL | 0.02 mg | ||
| Calcium Phosphate | CALCIUM PHOSPHATE | 97Z1WI3NDX | TABLET / ORAL | 183.94 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / VAGINAL | 4 %w/w | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, DELAYED RELEASE / ORAL | 144 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | INSERT / VAGINAL | 54.21 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 47 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | RING / VAGINAL | 2 mg |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.